Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer by Gold Heather Taffet, Hall Michael J, Blinder Victoria, Schackman Bruce R in Cancer (2009).

[PMID: 19517472] PubMed


The objective of this study was to examine the cost effectiveness of using a pharmacogenetic test for uridine diphosphate glycosyltransferase 1A1*28 (UGT1A1*28) variant homozygosity before administering irinotecan to patients with metastatic colorectal cancer.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.